Schultz, N. M. (2024). Synergy valuation in the Pfizer - seagen acquisition - influencing factors on abnormal returns in R & D intensive industries for Us acquirers.
Chicago Style (17th ed.) CitationSchultz, Noah Michael. Synergy Valuation in the Pfizer - Seagen Acquisition - Influencing Factors on Abnormal Returns in R & D Intensive Industries for Us Acquirers. 2024.
MLA (9th ed.) CitationSchultz, Noah Michael. Synergy Valuation in the Pfizer - Seagen Acquisition - Influencing Factors on Abnormal Returns in R & D Intensive Industries for Us Acquirers. 2024.
Warning: These citations may not always be 100% accurate.